The primary endpoints of the trial were stool weight, duration of diarrhea, stool frequency and stool consistency; additional endpoints followed include degree of patient dehydration and reduction in
Under the agreement with Diomed Holdings and Diomed Inc., AngioDynamics may provide up to $1.3 million in debtor-in-possession financing that will be secured by a perfected first priority
Under the terms of the agreement, Merck will pay Celera a license fee for the exclusive access to the 10 targets, in addition to the payment of development
Hi-Tech’s dorzolamide hydrochloride with timolol maleate ophthalmic solution is the generic equivalent of Merck’s Cosopt and is indicated for the treatment of glaucoma. The company believes that it
Lexiscan is claimed to be the first A2A adenosine receptor agonist shown to be safe and effective as a pharmacologic stress agent in myocardial perfusion imaging (MPI) studies.
The Phase III clinical trial results on which this approval was based demonstrated that Abraxane doubled the response rate and significantly prolonged progression-free survival and overall survival versus
According to the National Pharmaceutical Pricing Authority (NPPA), the budget’s reduction in countervailing duty (CVD) rate from 16% to 8% has lowered the prices of 36 of the
A Consumers Union (CU) survey in the US found that only 35% of the public were aware that they could report serious drug side effects to the FDA.
The Greek wholesalers took GSK to court after the company refused to supply them with shipments of epilepsy drug Lamictal (lamotrigine), the migraine treatment drug Imigran (sumatriptan) and
According to the report, Pfizer spent GBP3.88 billion for R&D in 2006 while Johnson & Johnson (J&J) invested GBP3.64 billion in research. While Pfizer pushed itself to the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.